Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Exosomal microRNA profiles in the aqueous humor of patients with primary open-angle glaucoma and exfoliation glaucoma
Author Affiliations & Notes
  • Do Young Park
    Samsung Medical Center Department of Ophthalmology, Gangnam-gu, Seoul, Korea (the Republic of)
  • Soo-Eun Sung
    Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Korea (the Republic of)
  • Tae Eun Kim
    Samsung Medical Center Department of Ophthalmology, Gangnam-gu, Seoul, Korea (the Republic of)
  • Sooncheol Cha
    Yeungnam University School of Medicine and College of Medicine, Daegu, Daegu, Korea (the Republic of)
  • Changwon Kee
    Kim's Eye Hospital, Seoul, Korea (the Republic of)
  • Jong Chul Han
    Samsung Medical Center Department of Ophthalmology, Gangnam-gu, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Do Young Park None; Soo-Eun Sung None; Tae Eun Kim None; Sooncheol Cha None; Changwon Kee None; Jong Chul Han None
  • Footnotes
    Support  National Research Foundation of Korea (2022R1C1C1008365)
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3555. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Do Young Park, Soo-Eun Sung, Tae Eun Kim, Sooncheol Cha, Changwon Kee, Jong Chul Han; Exosomal microRNA profiles in the aqueous humor of patients with primary open-angle glaucoma and exfoliation glaucoma. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3555.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Exosomes, small extracellular vesicles enclosed by a lipid bilayer, are present in the aqueous humor (AH) and play a role in intercellular communication, regulating biological processes. MicroRNAs (miRNAs) within exosomes, notably stable in AH, may modulate gene expression in ocular tissues, including the trabecular meshwork (TM). In this study, we investigated the exosomal miRNA profile in the AH of patients with primary open-angle glaucoma (POAG) and exfoliative glaucoma (XFG) and validated the role of individual miRNA in changes in TM cells.

Methods : Exosomes were isolated and pooled from AH samples of 14 healthy controls, 21 POAG patients, and 24 XFG patients using the precipitation method. Exosomes were confirmed by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and flow cytometry (FC). Exosomal miRNAs were analyzed by small-RNA sequencing. The role of individual miRNAs was validated in human TM (hTM) cells.

Results : Age did not significantly differ among groups. Exosomes in AH were confirmed by TEM, and CD9, CD63, and CD81 expression were validated through FC. In small-RNA sequencing, distinct microRNA clusters that were differentiated from the normal group were identified in both the POAG and XFG groups. In particular, several down-regulated miRNAs were commonly identified in the glaucoma groups compared to the normal group. Functional analysis identified alterations in miRNAs associated with TM cell fibrosis and extracellular matrix (ECM) remodeling, linked to TGF-beta signaling, Hippo signaling, actin cytoskeleton, and ECM organization in the glaucoma group. Among these, miR-375, which was significantly downregulated in POAG, was linked to the Hippo signaling pathway. Dexamethasone treatment reduced miR-375 expression in hTM cells, and a miR-375 inhibitor activated Hippo signaling, leading to increased expression of connective tissue growth factor (CTGF).

Conclusions : Significant changes in miRNA content were observed in the AH exosomes in patients with POAG and XFG. Altered miRNA content in the AH exosomes of POAG and XFG patients may impact trabecular meshwork cells via cell-to-cell communication, providing insights into potential targets for glaucoma treatment.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×